AKT1 and T-cell non-Hodgkin lymphoma: Particularly, given that both PDCD4 and PI3K/PTEN/AKT inhibit physiologically tumor promotion and progression and intravasation [161,162], their strong repression suggests that miR-21 overexpression may contribute to the typical characteristics of aggressive clinical-pathological NK/T-cell lymphoma.